The store will not work correctly when cookies are disabled.
Ethyl 3,11-dihydro-3-oxopyrano[3,2-a]carbazole-2-carboxylate
ID: ALA2414994
PubChem CID: 73346077
Max Phase: Preclinical
Molecular Formula: C18H13NO4
Molecular Weight: 307.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc2c(ccc3c4ccccc4[nH]c23)oc1=O
Standard InChI: InChI=1S/C18H13NO4/c1-2-22-17(20)13-9-12-15(23-18(13)21)8-7-11-10-5-3-4-6-14(10)19-16(11)12/h3-9,19H,2H2,1H3
Standard InChI Key: AYVGGVRTODEMSB-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
15.2709 -3.3069 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3605 -1.9692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7962 -2.6698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7450 -1.2443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5018 -2.9986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5580 -2.1722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8715 -1.7122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1283 -2.0775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0759 -2.9073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7632 -3.3635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6189 -2.6381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0520 -3.3340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8728 -3.3070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2587 -2.5782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0068 -1.9140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8199 -1.8874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5774 -1.2283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0878 -2.5454 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3125 -4.0107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9229 -4.7433 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1418 -3.9818 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.0936 -4.7722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7038 -5.5049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 6 1 0
5 1 1 0
1 3 1 0
2 3 2 0
3 11 1 0
17 4 2 0
4 2 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
15 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 16 1 0
15 16 1 0
17 15 1 0
14 18 2 0
13 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 307.31 | Molecular Weight (Monoisotopic): 307.0845 | AlogP: 3.60 | #Rotatable Bonds: 2 |
Polar Surface Area: 72.30 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.46 | CX Basic pKa: ┄ | CX LogP: 3.22 | CX LogD: 3.22 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.45 | Np Likeness Score: -0.08 |
References
1. Francisco CS, Rodrigues LR, Cerqueira NM, Oliveira-Campos AM, Rodrigues LM, Esteves AP.. (2013) Synthesis of novel psoralen analogues and their in vitro antitumor activity., 21 (17): [PMID:23886808] [10.1016/j.bmc.2013.06.049] |